Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate efficacy (clinical benefit) of two doses of ZK PRA (25 mg and 100 mg) when administered once daily p.o.
Inclusion criteria
- Metastatic breast cancer
To evaluate efficacy (clinical benefit) of two doses of ZK PRA (25 mg and 100 mg) when administered once daily p.o.